These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31405524)

  • 21. Postural Orthostatic Tachycardia Syndrome (POTS): A critical assessment.
    Olshansky B; Cannom D; Fedorowski A; Stewart J; Gibbons C; Sutton R; Shen WK; Muldowney J; Chung TH; Feigofsky S; Nayak H; Calkins H; Benditt DG
    Prog Cardiovasc Dis; 2020; 63(3):263-270. PubMed ID: 32222376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct neurohumoral biomarker profiles in children with hemodynamically defined orthostatic intolerance may predict treatment options.
    Wagoner AL; Shaltout HA; Fortunato JE; Diz DI
    Am J Physiol Heart Circ Physiol; 2016 Feb; 310(3):H416-25. PubMed ID: 26608337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular responses to orthostatic stress in patients with postural tachycardia syndrome (POTS), in patients with low orthostatic tolerance, and in asymptomatic controls.
    Bush VE; Wight VL; Brown CM; Hainsworth R
    Clin Auton Res; 2000 Oct; 10(5):279-84. PubMed ID: 11198483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Orthostatic intolerance without postural tachycardia: how much dysautonomia?
    Parsaik AK; Singer W; Allison TG; Sletten DM; Joyner MJ; Benarroch EE; Low PA; Sandroni P
    Clin Auton Res; 2013 Aug; 23(4):181-8. PubMed ID: 23729158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postural Tachycardia Syndrome: Diagnosis and Management in Adolescents and Young Adults.
    Heyer GL
    Pediatr Ann; 2017 Apr; 46(4):e145-e154. PubMed ID: 28414396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postural Orthostatic Tachycardia Syndrome: Mechanisms and New Therapies.
    Mar PL; Raj SR
    Annu Rev Med; 2020 Jan; 71():235-248. PubMed ID: 31412221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Self-reported symptom burden in postural orthostatic tachycardia syndrome (POTS): A narrative review of observational and interventional studies.
    Knoop I; Picariello F; Jenkinson E; Gall N; Chisari C; Moss-Morris R
    Auton Neurosci; 2023 Jan; 244():103052. PubMed ID: 36525900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The preponderance of initial orthostatic hypotension in postural tachycardia syndrome.
    Stewart JM; Kota A; O'Donnell-Smith MB; Visintainer P; Terilli C; Medow MS
    J Appl Physiol (1985); 2020 Sep; 129(3):459-466. PubMed ID: 32702262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of lower body negative pressure on cardiac and cerebral function in postural orthostatic tachycardia syndrome: A pilot MRI assessment.
    Skow RJ; Foulkes SJ; Seres P; Freer MA; Mathieu ED; Raj SR; Thompson RB; Haykowsky MH; Richer L
    Physiol Rep; 2024 Mar; 12(6):e15979. PubMed ID: 38490814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical analysis and follow-up study of postural orthostatic tachycardia syndrome in 28 pediatric cases].
    Zhang QY; Du JB; Li WZ
    Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):165-9. PubMed ID: 15833184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postural orthostatic tachycardia syndrome: diagnosis and treatment.
    Thanavaro JL; Thanavaro KL
    Heart Lung; 2011; 40(6):554-60. PubMed ID: 21329983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gluten-free diet in postural orthostatic tachycardia syndrome (POTS).
    Zha K; Brook J; McLaughlin A; Blitshteyn S
    Chronic Illn; 2023 Jun; 19(2):409-417. PubMed ID: 35098721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Menstrual cycle phase does not affect sympathetic neural activity in women with postural orthostatic tachycardia syndrome.
    Stickford AS; VanGundy TB; Levine BD; Fu Q
    J Physiol; 2015 May; 593(9):2131-43. PubMed ID: 25656420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypocapnic cerebral hypoperfusion: A biomarker of orthostatic intolerance.
    Novak P
    PLoS One; 2018; 13(9):e0204419. PubMed ID: 30256820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Erythropoietin in the treatment of postural orthostatic tachycardia syndrome.
    Kanjwal K; Saeed B; Karabin B; Kanjwal Y; Sheikh M; Grubb BP
    Am J Ther; 2012 Mar; 19(2):92-5. PubMed ID: 20838326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autonomic dysfunction presenting as postural orthostatic tachycardia syndrome in patients with multiple sclerosis.
    Kanjwal K; Karabin B; Kanjwal Y; Grubb BP
    Int J Med Sci; 2010 Mar; 7(2):62-7. PubMed ID: 20309394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comorbidity of postural orthostatic tachycardia syndrome and chronic fatigue syndrome in an Australian cohort.
    Reynolds GK; Lewis DP; Richardson AM; Lidbury BA
    J Intern Med; 2014 Apr; 275(4):409-17. PubMed ID: 24206536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postural Orthostatic Tachycardia Syndrome: Prevalence, Pathophysiology, and Management.
    Zadourian A; Doherty TA; Swiatkiewicz I; Taub PR
    Drugs; 2018 Jul; 78(10):983-994. PubMed ID: 29943373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteomic analysis reveals sex-specific biomarker signature in postural orthostatic tachycardia syndrome.
    Medic Spahic J; Ricci F; Aung N; Hallengren E; Axelsson J; Hamrefors V; Melander O; Sutton R; Fedorowski A
    BMC Cardiovasc Disord; 2020 Apr; 20(1):190. PubMed ID: 32321428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and physiological effects of an acute alpha-1 adrenergic agonist and a beta-1 adrenergic antagonist in chronic orthostatic intolerance.
    Stewart JM; Munoz J; Weldon A
    Circulation; 2002 Dec; 106(23):2946-54. PubMed ID: 12460877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.